Scott L. Carter
Molecular Biology · 2004–2015
A researcher in the Science corpus: 42 papers; trusts 3 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 676 citations into it; #13,958 of 17,773 by trust here, #173 by citations
Whom Scott L. Carter trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Atul J. Butte
- Z. Storchová
- Pablo Tamayo
- Audrey P. Gasch
- Arthur P. Dempster
- A. Rényi
- R. Kamath
- Wolfgang Huber
- Peter Uetz
- Craig H. Mermel
Who trusts Scott L. Carter overall
- Nicholas McGranahan
- Seyoung Kim
- Ronglai Shen
- T. Davoli
- Charles Swanton
- Niko Beerenwinkel
- Eric P. Xing
- Tommaso Cai
- Levi A. Garraway
- Venkatraman E. Seshan
Papers from Scott L. Carter's perspective
Ordered by how strongly the researchers Scott L. Carter trusts endorse each paper. Same corpus, a different order for every researcher.
- Malignant astrocytic glioma: genetics, biology, and paths to treatment. (Genes & Development)
- GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers (Genome Biology)
- Molecular portraits of human breast tumours (Nature)
- The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity (Nature)
- Discovery and saturation analysis of cancer genes across 21 tumor types (Nature)
- Systematic identification of genomic markers of drug sensitivity in cancer cells (Nature)
- Predicting the functional impact of protein mutations: application to cancer genomics
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer (Nature Genetics)
- Accurate Whole Human Genome Sequencing using Reversible Terminator Chemistry (Nature)
- Identification of genes periodically expressed in the human cell cycle and their expression in tumors. (Molecular Biology of the Cell)
Their papers
- High-resolution mapping of copy-number alterations with massively parallel sequencing (2008) — 550 citations
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer (2012) — 1,524 citations
- Comprehensive molecular portraits of human breast tumors (2012) — 7,518 citations
- The Mutational Landscape of Head and Neck Squamous Cell Carcinoma (2011) — 2,541 citations
- Comprehensive Molecular Characterization of Human Colon and Rectal Cancer (2012) — 7,754 citations
- Mutational heterogeneity in cancer and the search for new cancer genes (2013) — 1,147 citations
- An APOBEC Cytidine Deaminase Mutagenesis Pattern is Widespread in Human Cancers (2013) — 1,129 citations
- The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma. (2014) — 705 citations
- Melanoma genome sequencing reveals frequent PREX2 mutations (2012) — 752 citations
- Evolution and impact of subclonal mutations in chronic lymphocytic leukemia (2013) — 1,402 citations
- The genetic landscape of high-risk neuroblastoma (2013) — 1,115 citations
- Punctuated Evolution of Prostate Cancer Genomes (2013) — 1,269 citations
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways (2008) — 7,050 citations
- Comprehensive molecular profiling of lung adenocarcinoma (2014) — 5,176 citations
- Gene co-expression network topology provides a framework for molecular characterization of cellular state (2004) — 355 citations
- A tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1 (2013) — 1,053 citations
- Sequence analysis of mutations and translocations across breast cancer subtypes (2012) — 1,207 citations
- MEDULLOBLASTOMA EXOME SEQUENCING UNCOVERS SUBTYPE-SPECIFIC SOMATIC MUTATIONS (2012) — 755 citations
- Genomic Classification of Cutaneous Melanoma (2015) — 2,764 citations
- Integrated Genomic Characterization of Papillary Thyroid Carcinoma (2014) — 2,692 citations